Proportion of Patients in the United States Who Fill Their Nirmatrelvir/Ritonavir Prescriptions
Abstract Introduction Although real-world studies demonstrate that those prescribed nirmatrelvir/ritonavir (and particularly within 5 days of symptom onset) are less likely to experience severe COVID-19 outcomes, prior studies show that only a small fraction of patients with COVID-19 who are eligibl...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Adis, Springer Healthcare
2024-08-01
|
| coleção: | Infectious Diseases and Therapy |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1007/s40121-024-01023-z |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|